Protagonist Therapeutics PTGX
NASDAQ PTGX
$143.45 +2.48 (+1.76%)
As of: Sep 30, 2026 · 11:53 AM EDT

Protagonist Therapeutics (PTGX) Operating Expenses (2015 - 2026)

Updated

Protagonist Therapeutics' Operating Expenses came in at $54.71 million for Q2 2026, up 15.0% from $47.59 million a year earlier but down 8.8% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Operating Expenses (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Protagonist Therapeutics reported Operating Expenses of $223.65 million, up 20.8% year-over-year; for FY2025, it was $204.14 million, up 12.4% from FY2024.

  • Operating Expenses carries a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $181.59 million in FY2024 (+18.2%), $153.65 million in FY2023 (-2.7%), $157.95 million in FY2022 (+3.1%) and $153.2 million in FY2021 (+64.5%).
  • The five-year range for quarterly Operating Expenses is $32.3 million (Q3 2022) to $60.02 million (Q1 2026).
  • Year-over-year, Operating Expenses has increased for five consecutive quarters, with growth averaging 16.4% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q3 2021 (growth of 111.7%), and the weakest in Q3 2022 (a decline of 26.9%).
  • Business Quant data shows PTGX's Operating Expenses at $60.02 million (Q1 2026), $57.79 million (Q4 2025) and $51.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Protagonist Therapeutics 9.21 Bn 9.21 Bn - 54.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.71 Mn
Mar 31, 2026 60.02 Mn
Dec 31, 2025 57.79 Mn
Sep 30, 2025 51.13 Mn
Jun 30, 2025 47.59 Mn
Mar 31, 2025 47.63 Mn
Dec 31, 2024 43.86 Mn
Sep 30, 2024 46.13 Mn
Jun 30, 2024 42.96 Mn
Mar 31, 2024 48.64 Mn
Dec 31, 2023 36.95 Mn
Sep 30, 2023 38.33 Mn
Jun 30, 2023 42.35 Mn
Mar 31, 2023 36.02 Mn
Dec 31, 2022 36.52 Mn
Sep 30, 2022 32.30 Mn
Jun 30, 2022 42.30 Mn
Mar 31, 2022 46.83 Mn
Dec 31, 2021 45.63 Mn
Sep 30, 2021 44.21 Mn
API Access

Protagonist Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PTGX&period=max&api_key=YOUR_API_KEY